Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.04, $0.02 better than the analyst estimate of $2.02. Revenue for the quarter came in at $22.52 billion versus the consensus estimate of $22.46 billion.

GUIDANCE:

Johnson & Johnson sees FY2025 EPS of $10.50-$10.70, versus the consensus of $10.60.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.